Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3665 SEK | -2.01% | -0.95% | -62.98% |
Apr. 24 | Episurf Medical Announces Distributor Agreement with Depuy-Synthes | CI |
Apr. 24 | Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 17.12M 1.56M | Sales 2025 * | 36.71M 3.34M | Capitalization | 100M 9.11M |
---|---|---|---|---|---|
Net income 2024 * | -69M -6.28M | Net income 2025 * | -57M -5.19M | EV / Sales 2024 * | -0.46 x |
Net cash position 2024 * | 108M 9.83M | Net Debt 2025 * | 53M 4.83M | EV / Sales 2025 * | 4.17 x |
P/E ratio 2024 * |
-2.49
x | P/E ratio 2025 * |
-3.87
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.85% |
1 day | -2.01% | ||
1 week | -0.95% | ||
Current month | -54.75% | ||
1 month | -54.02% | ||
3 months | -64.76% | ||
6 months | -58.87% | ||
Current year | -62.98% |
Managers | Title | Age | Since |
---|---|---|---|
Pål Ryfors
CEO | Chief Executive Officer | 41 | 15-12-13 |
Patrick Jamnik
PSD | President | 41 | 20-12-31 |
Veronica Wallin
DFI | Director of Finance/CFO | 38 | 16-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Laura Shunk
BRD | Director/Board Member | 67 | 17-05-21 |
Ulf Grunander
CHM | Chairman | 70 | 21-04-30 |
Director/Board Member | 62 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.3665 | -2.01% | 15 156 |
24-04-29 | 0.374 | +4.18% | 1,868,237 |
24-04-26 | 0.359 | -2.45% | 1,609,374 |
24-04-25 | 0.368 | -7.65% | 1,227,741 |
24-04-24 | 0.3985 | +7.70% | 2,619,557 |
Delayed Quote Nasdaq Stockholm, April 30, 2024 at 03:36 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-62.98% | 9.16M | |
+13.16% | 129B | |
-9.30% | 10.77B | |
+3.60% | 9.05B | |
+19.75% | 7.38B | |
+22.28% | 4.88B | |
+7.55% | 3.41B | |
-0.21% | 3.07B | |
-4.80% | 2.24B | |
-4.72% | 2.12B |
- Stock Market
- Equities
- EPIS B Stock